» Articles » PMID: 16144876

Differential Amplification of Murine Bipotent Megakaryocytic/erythroid Progenitor and Precursor Cells During Recovery from Acute and Chronic Erythroid Stress

Overview
Journal Stem Cells
Date 2005 Sep 8
PMID 16144876
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Two murine bipotent erythroid/megakaryocytic cells, the progenitor (MEP) and precursor (PEM) cells, recently have been identified on the basis of the phenotypes of linnegc-kitposSca-1neg CD16/CD32lowCD34low and TER119pos4A5pos or 2D5pos, respectively. However, the functional relationship between these two subpopulations and their placement in the hemopoietic hierarchy is incompletely understood. We compared the biological properties of these subpopulations in marrow and spleen of mice with and without acute or chronic erythroid stress. MEP cells, but not PEM cells, express c-kit, respond to stem cell factor in vitro, and form spleen colonies in vivo. PEM cells comprise up to 50%-70% of the cells in BFU-E-derived colonies but are not present among the progeny of purified MEP cells cultured under erythroid and megakaryocytic permissive conditions. PEM cells increase 10- to 20-fold under acute and chronic stress, whereas MEP cell increases (21%-84%) are observed only in acutely stressed animals. These data suggest that MEP and PEM cells represent distinct cell populations that may exist in an upstream-downstream differentiation relationship under conditions of stress. Whereas the dynamics of both populations are altered by stress induction, the differential response to acute and chronic stress suggests different regulatory mechanisms. A model describing the relationship between MEP, PEM, and common myeloid progenitor cells is presented.

Citing Articles

Multistage hematopoietic stem cell regulation in the mouse: A combined biological and mathematical approach.

Bonnet C, Gou P, Girel S, Bansaye V, Lacout C, Bailly K iScience. 2021; 24(12):103399.

PMID: 34877482 PMC: 8627979. DOI: 10.1016/j.isci.2021.103399.


Novel targets to cure primary myelofibrosis from studies on Gata1 mice.

Zingariello M, Martelli F, Verachi P, Bardelli C, Gobbo F, Mazzarini M IUBMB Life. 2019; 72(1):131-141.

PMID: 31749302 PMC: 7256843. DOI: 10.1002/iub.2198.


GATA1 insufficiencies in primary myelofibrosis and other hematopoietic disorders: consequences for therapy.

Ling T, Crispino J, Zingariello M, Martelli F, Migliaccio A Expert Rev Hematol. 2018; 11(3):169-184.

PMID: 29400094 PMC: 6108178. DOI: 10.1080/17474086.2018.1436965.


The thrombopoietin/MPL axis is activated in the Gata1 mouse model of myelofibrosis and is associated with a defective RPS14 signature.

Zingariello M, Sancillo L, Martelli F, Ciaffoni F, Marra M, Varricchio L Blood Cancer J. 2017; 7(6):e572.

PMID: 28622305 PMC: 5520398. DOI: 10.1038/bcj.2017.51.


Evolving insights into the synergy between erythropoietin and thrombopoietin and the bipotent erythroid/megakaryocytic progenitor cell.

Papayannopoulou T, Kaushansky K Exp Hematol. 2016; 44(8):664-8.

PMID: 26773569 PMC: 4938787. DOI: 10.1016/j.exphem.2015.11.010.